The New York Times: Health
India, a major source of inexpensive AIDS drugs, passed a new patent law because drug makers will have the same 20-year patent monopolies as they
|
NPR : India Considers Drug-Patent Law
The Indian government considers the adoption of a bill that makes it illegal to copy patented drugs, a practice that has made cheaper medicines available in
|
Forbes.com: Are Drug Patents Too Short?
boost the drug's $2.8 billion-per-year US sales, it is facing a patent Expensive clinical trials that come just as a drug is losing its patent
|
Prescription Drug Patents
that drugs are costly is that the government grants manufacturers patent to tweak a currently patented drug enough to extend the patent life so they
|
AIDS Drug Patents
AIDS Drug Patents. Recent developments in Canada to fight this human tragedy: the notion of ignoring patents in favor of developing badly needed drugs.
|
-
High-Stakes Biotech GameFight Fire With Fire: Using virus to beat antibiotic-resistaTaq PCR Patent Litigation Part I - Biotech/Biomedical Indust
|
India to Protect Drug Patents
India's patent system has historically not protected drugs, enabling India to develop international leadership in the production of generic drugs.
|
India passes the drug Patent Bill
? India's parliament passed a new law Wednesday, the Patent (Amendment) Bill, prohibiting the copying of patented drugs, despite strong criticism that the
|
FT.com / World - India drug patent law clears its first hurdle
India drug patent law clears its first hurdle By Jo Johnson in New Delhi and Andrew Jack in London Published: March 22 2005 20:18 | Last updated: March
|
AlterNet: High Cipro Prices Bring Drug Patent Issue Home
The drug patent issue has been a major point of contention in recent AIDS activists have accused patent-holding drug companies of promoting a form
|
Pharmaceuticals - Patent Expirations by Drug Name
Home > Pharmaceuticals > Pharma Patent Info > Expirations by Drug Name, NEW! See Also: DialogOne IP for Patent Family or Legal Status information.
|
RED HERRING | Drug patents for India
Drug patents for India. India?s government proposes western-style patent laws to make it illegal to copy drugs protected by intellectual property laws
|
RED HERRING | Drug patents for India
Drug patents for India. India?s government proposes western-style patent laws to make it illegal to copy drugs protected by intellectual property laws
|
Public Citizen | Drug Patent Issues - Drug Patent Issues & Generic
Drug Patent Issues & Generic Drugs. » congress | reform | drug patents Pediatric Monopoly Patent Extension. Publications
|
Indian parliament approves drug patents bill. 24/03/2005. ABC News
Indian parliaments upper house has approved a controversial drug patents bill which critics warn could deprive millions of poor people of low-cost life
|
DNApatent.com - Getting and Using Competitive Intelligence on Drug
Profiting from Drug Patents: Collecting Competitive Patent Intelligence.
|
End of era for Indian generics
Critics warn that new drug patent law hurts the poor India As the Indian Parliament granted final approval Wednesday to drug patent protections,
|
FindLaw's Writ - Mariner: Profit Margins, Death Rates, Drug
companies twenty years of protection for drug patents filed after 1995. are likely to go beyond the WTO's rules in protecting drug patents.
|
Forbes.com: Solving The Drug Patent Problem
Our Solution: Give drug patents a shorter term of 15 years but don't system becomes complicated as drug companies file patent upon patent to try to
|
C&EN: LATEST NEWS - India Moves On Drug Patents
India pledged to change its laws on drug patents when it joined the World Trade patents in 1970 to encourage the supply of affordable drugs to its
|
Aljazeera.Net - New Indian drug patent law decried
's passage of a new patent law that will stop domestic drug companies from inventions" to prevent drug companies from winning new patents by making
|
American Prospect Online - ViewWeb
the patented drug company would be given ?just compensation? for the patent. "Patents Pending", The American Prospect Online, Feb 23, 2005.
|
